Dr. Mike Curtis, a Liverpool High School, ESF, and Upstate Medical graduate, has made waves in the medical field as the CEO of eGenesis, a biotechnology company responsible for a groundbreaking achievement. The company recently provided the first pig kidney transplanted into a living human, offering hope to thousands of patients on the kidney transplant waitlist.
This monumental accomplishment is the result of years of research in organ reduction technology, genome engineering, cloning, and immune suppression. The breakthrough represents a major step forward in addressing the critical shortage of human organs for those in need of transplants. Dr. Curtis and his team at eGenesis are focused on providing a renewable and compatible supply of organs to save lives and improve the quality of life for patients worldwide.
In addition to their work with kidney transplants, eGenesis is also exploring programs for treating acute liver failure and utilizing a porcine heart to bridge the gap for children waiting for a human heart transplant. Dr. Curtis believes that this technology has the potential to revolutionize the organ transplant space and significantly impact the lives of those in need.
The success of eGenesis in the field of organ transplantation is a testament to the power of innovation and dedication in the medical community. Patients on dialysis, those with renal failure, and others in need of life-saving transplants can now look towards a brighter future thanks to the groundbreaking work of Dr. Mike Curtis and his team at eGenesis.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”